Linda Mol

4.2k citations

45 papers · 2.7k indexed · 1 hit paper · h-index 20

Oncology top 1%
- Colorectal Cancer Treatments and Studies 36
- Cancer Treatment and Pharmacology 12
- Colorectal Cancer Surgical Treatments 5
- Colorectal Cancer Screening and Detection 4
Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 10
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer 12
Pulmonary and Respiratory Medicine top 2%
- Gastric Cancer Management and Outcomes 15
Cancer Research top 10%
Surgery
- Orthopedic Infections and Treatments 3

Co-authors: Cornelis J.A. Punt Miriam Koopman Ninja Antonini C. J. Rodenburg Frans Erdkamp Harm Sinnige Otilia Dalesio Jolanda Schrama
Cited by: Oncology Hepatology Pathology and Forensic Medicine
Journals: Journal of Clinical Oncology (11 papers)European Journal of Cancer (5 papers)Annals of Oncology (5 papers)
Partner nations: Netherlands United States Denmark

In The Last Decade

Linda Mol

45 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Linda Mol

Since Specialization

Citations

This map shows the geographic impact of Linda Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Mol more than expected).

Fields of papers citing papers by Linda Mol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Mol. The network helps show where Linda Mol may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Linda Mol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linda Mol Line = papers co-authored together Linda Mol links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Sanne ten Hoorn,Linda Mol,Dirkje W. Sommeijer,Lisanne E. Nijman,Tom van den Bosch,Tim R. de Back,Bauke Ylstra,Erik van Dijk,Carel J.M. van Noesel,Roy J. Reinten,Irıs D. Nagtegaal,Miriam Koopman,Cornelis J.A. Punt,Louis Vermeulen	2022	4
2	Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer BMC Cancer ·Sanne ten Hoorn,Cynthia Waasdorp,Martijn G.H. van Oijen,Helene Damhofer,Anne Trinh,Lan Zhao,Tiffany Tan,Sanne Bootsma,Gabi W. van Pelt,Wilma E. Mesker,Linda Mol,Ahdha Jangga Buwana,Miriam Koopman,Jan Paul Medema,Jurriaan B. Tuynman,Inti Zlobec,Cornelis J.A. Punt,Louis Vermeulen,Maarten F. Bijlsma	2022	7
3	Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab PLoS ONE ·Jara M. Baas,Janice O. Bennett,Stefan Böhringer,Linda Mol,Cornelis J.A. Punt,Henk‐Jan Guchelaar,Hans Gelderblom	2018	6
4	Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Annals of Oncology ·Johannes J.M. Kwakman,Lieke H. J. Simkens,Johan M. van Rooijen,Agnès J. van de Wouw,Albert J. ten Tije,G.J. Creemers,Mathijs P. Hendriks,Maartje Los,R J van Alphen,M. Polée,E.W. Muller,Ankie M.T. van der Velden,Theo van Voorthuizen,Miriam Koopman,Linda Mol,Erik van Werkhoven,Cornelis J.A. Punt	2017	47
5	Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer European Journal of Cancer ·P.J. Arango-Arango,B. I. Olson,Anne M. May,Hendrik Koffijberg,Harm van Tinteren,Linda Mol,Albert J. ten Tije,G.J. Creemers,Ankie M.T. van der Velden,Bea C. Tanis,Carin A. Uyl‐de Groot,Cornelis J.A. Punt,Miriam Koopman,Martijn G.H. van Oijen	2017	19
6	Randomized phase 3 study of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (mCRC): The SALTO study of the Dutch Colorectal Cancer Group. Journal of Clinical Oncology ·Cornelis J.A. Punt,Lieke H. J. Simkens,Johan van Rooijen,Chirine Ben Abdallah,O. J. L. Loosveld,Geert‐Jan Creemers,Mathijs P. Hendriks,Maartje Los,Robbert J. van Alphen,Marco B. Polée,E.W. Muller,Uta Pertschy,Beatriz Tavares Batista,Miriam Koopman,Linda Mol,Johannes J.M. Kwakman,Erik van Werkhoven	2016	2
7	The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients European Journal of Cancer ·Linda Mol,Petronella B. Ottevanger,Miriam Koopman,Cornelis J.A. Punt	2016	39
8	Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG) BMC Cancer ·Joost Huiskens,Thomas M. van Gulik,Krijn P. van Lienden,健市稲穂,Gerrit A. Meijer,Nicole C.T. van Grieken,Xufeng Niu,Astrid Keijser,Linda Mol,I. Quintus Molenaar,Cornelis Verhoef,Koert P. de Jong,M. Gallagher,Geert Kazemier,Theo Ruers,Rezvan Bahmani,Harm van Tinteren,Cornelis J.A. Punt	2015	41
9	Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands Acta Oncologica ·Linda Mol,Miriam Koopman,Hidehiko Kumagai,Petronella B. Ottevanger,Cornelis J.A. Punt	2013	42
10	Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature Indian Journal of Surgical Oncology ·Sabine Venderbosch,Johannes H.W. de Wilt,Steven Teerenstra,O. J. L. Loosveld,Aart van Bochove,Harm Sinnige,Geert-Jan Creemers,Margot Tesselaar,Linda Mol,Cornelis J.A. Punt,Miriam Koopman	2012	7
11	Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy European Journal of Cancer ·Lieke H. J. Simkens,Miriam Koopman,Linda Mol,G.J. Veldhuis,Daan ten Bokkel Huinink,E.W. Muller,Моренова Ксения Александровна,Steven Teerenstra,Cornelis J.A. Punt	2011	74
12	Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature Annals of Surgical Oncology ·Sabine Venderbosch,Johannes H.W. de Wilt,Steven Teerenstra,O. J. L. Loosveld,Aart van Bochove,Harm Sinnige,Geert-Jan Creemers,Margot Tesselaar,Linda Mol,Cornelis J.A. Punt,Miriam Koopman	2011	125
13	異時性対同時性転移性結腸直腸癌(CRC)における臨床像と病理像 Annals of Oncology ·Mikkel Langager Larsen,Mmw Koopman,Steven Teerenstra,Hamida Bekakria,Linda Mol,Irıs D. Nagtegaal,А.С. Бугайченко	2010	13
14	Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy Annals of Oncology ·L.B.J. van Iersel,Miriam Koopman,Cornelis J.�H. van de Velde,Linda Mol,Daniel Guettler,H.H. Hartgrink,Peter J.K. Kuppen,Alexander L. Vahrmeijer,J.W.R. Nortier,Robert A.E.M. Tollenaar,Cornelis J.A. Punt,Hans Gelderblom	2010	17
15	The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients European Journal of Cancer ·Nikki Knijn,J. Tol,Miriam Koopman,Romilda Rodrigues do Nascimento,Alex L.T. Imholz,F.A.A. Valster,Linda Mol,Andrew Vincent,Steven Teerenstra,Cornelis J.A. Punt	2010	39
16	Current Questions in the Treatment of Advanced Colorectal Cancer: The CAIRO Studies of the Dutch Colorectal Cancer Group Clinical Colorectal Cancer ·Lieke H. J. Simkens,Jolien Tol,Miriam Koopman,Linda Mol,Ninja Antonini,Anca Agachi,Cornelis J.A. Punt	2008	6
17	Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial The Lancet ·Miriam Koopman,Ninja Antonini,Jorge Espinoza Torres,J. Wals,Aafke H. Honkoop,Frans Erdkamp,Robert S. de Jong,C. J. Rodenburg,Gerard Vreugdenhil,O. J. L. Loosveld,Aart van Bochove,Harm Sinnige,Geert-Jan Creemers,Margot Tesselaar,P. H. Th. J. Slee,Romilda Rodrigues do Nascimento,Linda Mol,Otilia Dalesio,Cornelis J.A. Punt	2007	461
18	Correction of Error in Two-dimensional Wear Measurements of Cemented Hip Arthroplasties Clinical Orthopaedics and Related Research ·Bertram Thé,Linda Mol,Ron L. Diercks,Peter M. A. van Ooijen,Nico Verdonschot	2006	6
19	Late sequelae of neonatal septic arthritis of the shoulder Journal of Bone and Joint Surgery - British Volume ·Cees F. A. Bos,Linda Mol,Willem R. Obermann,Evelien Ton	1998	20
20	An open multicentre prospective study of the effects of monotherapy with controlled-release carbamazepine on newly diagnosed generalized tonic-clonic seizures Seizure ·Peter Paul De Deyn,Linda Mol,Yunbo Ding,Álvaro Henrique de Araújo Rungue	1994	3

About Linda Mol

Linda Mol is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (36 papers), Gastric Cancer Management and Outcomes (15 papers), Genetic factors in colorectal cancer (12 papers), Cancer Treatment and Pharmacology (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Surgical Treatments (5 papers), Colorectal Cancer Screening and Detection (4 papers) and Orthopedic Infections and Treatments (3 papers). The work is most often cited by research in Oncology (2.2k citations), Hepatology (627 citations) and Pathology and Forensic Medicine (555 citations). Linda Mol has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Cornelis J.A. Punt, Miriam Koopman, Ninja Antonini, C. J. Rodenburg, Frans Erdkamp, Harm Sinnige, Otilia Dalesio, Jolanda Schrama, Allert H. Vos and Annemieke Cats. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Clinical Colorectal Cancer and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact